ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

The Cancer Letter Offers FAX Delivery

January 7, 1994

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

Clinton Proposes Increase For Science And Technology.

February 4, 2000

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007